Skip to main content
Top
Literature
2.
go back to reference Nishime EO, Cole CR, Blackstone EH, Pashkow FJ, Lauer MS (2000) Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA 284:1392–1398PubMedCrossRef Nishime EO, Cole CR, Blackstone EH, Pashkow FJ, Lauer MS (2000) Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA 284:1392–1398PubMedCrossRef
3.
go back to reference Cole CR, Foody JM, Blackstone EH, Lauer MS (2000) Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohort. Ann Intern Med 132:552–555PubMed Cole CR, Foody JM, Blackstone EH, Lauer MS (2000) Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohort. Ann Intern Med 132:552–555PubMed
4.
go back to reference Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS (1999) Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 341:1351–1357PubMedCrossRef Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS (1999) Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 341:1351–1357PubMedCrossRef
5.
go back to reference Arai Y, Saul JP, Albrecht P, Hartley JH, Lilly LS, Cohen RJ, Colucci WS (1989) Modulation of cardiac autonomic activity during and immediately after exercise. Am J Physiol 256:H132–H141PubMed Arai Y, Saul JP, Albrecht P, Hartley JH, Lilly LS, Cohen RJ, Colucci WS (1989) Modulation of cardiac autonomic activity during and immediately after exercise. Am J Physiol 256:H132–H141PubMed
6.
go back to reference Grassi G, Facchini A, Trevano FQ, Dell’Oro R, Arenare F, Tana F, Bolla G, Monzoni A, Robuschi M, Mancia G (2005) Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension 46:321–325PubMedCrossRef Grassi G, Facchini A, Trevano FQ, Dell’Oro R, Arenare F, Tana F, Bolla G, Monzoni A, Robuschi M, Mancia G (2005) Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension 46:321–325PubMedCrossRef
7.
go back to reference Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897–1904PubMedCrossRef Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897–1904PubMedCrossRef
8.
go back to reference Belozeroff V, Berry RB, Khoo MC (2003) Model-based assessment of autonomic control in obstructive sleep apnea syndrome. Sleep 26:65–73PubMed Belozeroff V, Berry RB, Khoo MC (2003) Model-based assessment of autonomic control in obstructive sleep apnea syndrome. Sleep 26:65–73PubMed
9.
go back to reference Chien MY, Lee P, Tsai YF, Yang PC, Wu YT (2011) C-reactive protein and heart rate recovery in middle-aged men with severe obstructive sleep apnea. Sleep Breath. doi:10.1007/s11325-011-0550-9 Chien MY, Lee P, Tsai YF, Yang PC, Wu YT (2011) C-reactive protein and heart rate recovery in middle-aged men with severe obstructive sleep apnea. Sleep Breath. doi:10.​1007/​s11325-011-0550-9
10.
go back to reference Vanhecke TE, Franklin BA, Zalesin KC, Sangal RB, deJong AT, Agrawal V, McCullough PA (2008) Cardiorespiratory fitness and obstructive sleep apnea syndrome in morbidly obese patients. Chest 134:539–545PubMedCrossRef Vanhecke TE, Franklin BA, Zalesin KC, Sangal RB, deJong AT, Agrawal V, McCullough PA (2008) Cardiorespiratory fitness and obstructive sleep apnea syndrome in morbidly obese patients. Chest 134:539–545PubMedCrossRef
11.
go back to reference Maeder MT, Munzer T, Rickli H, Schoch OD, Korte W, Hurny C, Ammann P (2008) Association between heart rate recovery and severity of obstructive sleep apnea syndrome. Sleep Med 9:753–761PubMedCrossRef Maeder MT, Munzer T, Rickli H, Schoch OD, Korte W, Hurny C, Ammann P (2008) Association between heart rate recovery and severity of obstructive sleep apnea syndrome. Sleep Med 9:753–761PubMedCrossRef
12.
go back to reference Hargens TA, Guill SG, Zedalis D, Gregg JM, Nickols-Richardson SM, Herbert WG (2008) Attenuated heart rate recovery following exercise testing in overweight young men with untreated obstructive sleep apnea. Sleep 31:104–110PubMed Hargens TA, Guill SG, Zedalis D, Gregg JM, Nickols-Richardson SM, Herbert WG (2008) Attenuated heart rate recovery following exercise testing in overweight young men with untreated obstructive sleep apnea. Sleep 31:104–110PubMed
13.
go back to reference Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G (1995) Sympathetic activation in obese normotensive subjects. Hypertension 25:560–563PubMedCrossRef Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G (1995) Sympathetic activation in obese normotensive subjects. Hypertension 25:560–563PubMedCrossRef
14.
go back to reference Maeder MT, Ammann P, Schoch OD, Rickli H, Korte W, Hurny C, Myers J, Munzer T (2010) Determinants of postexercise heart rate recovery in patients with the obstructive sleep apnea syndrome. Chest 137:310–317PubMedCrossRef Maeder MT, Ammann P, Schoch OD, Rickli H, Korte W, Hurny C, Myers J, Munzer T (2010) Determinants of postexercise heart rate recovery in patients with the obstructive sleep apnea syndrome. Chest 137:310–317PubMedCrossRef
Metadata
Title
Heart rate recovery in obstructive sleep apnea: obesity or not?
Author
Trent A. Hargens
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
Sleep and Breathing / Issue 1/2013
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-012-0650-1

Other articles of this Issue 1/2013

Sleep and Breathing 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine